
A class of FDA-approved cancer drugs may be able to prevent problems with brain cell development associated with disorders including Down syndrome and Fragile X syndrome, researchers have found.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/twYrcYYMO4E/150519121824.htm